Global Cannula Market Share Grows Steadily at a CAGR of 7.45%

Introduction

Straits Research released its highly anticipated report, “Global Cannula Market Size & Outlook, 2026-2034”. According to the study, the global market size is valued at USD 204.22 million in 2025 and is anticipated to grow to USD 388.52 million by 2034, growing at a CAGR of 7.45% from 2026-2034.

Market Dynamics

The market growth is primarily attributed to the increasing demand for oxygen therapy, the rising number of surgical procedures, the preference for disposable cannulas to reduce infections, and technological advancements in cannula design for better patient safety and comfort. In addition, the increasing number of chronic respiratory disease patients is driving the demand for nasal cannulas. For example, in June 2025, as per the data reported by the World Health Organization, more than 80 million people are affected by chronic respiratory diseases worldwide. Such a factor underscores the critical need for effective and accessible respiratory solutions, which further drives the demand for nasal cannulas. Moreover, innovations in cannula design are creating market opportunities by improving treatment outcomes. For example, in April 2024, as per the data reported in National Library of Medicine, researchers at Cornell University, U.S. developed a cannula that can automatically adjust its insulin dosage based on the blood glucose levels, without the electrical components. Such innovations create opportunities by improving treatment outcomes and by increasing demand for safer and more efficient cannulas.

Market Highlights

• Product: The Intravenous cannula dominated the market in 2025 with a revenue share of 53%.
• Application: The Oxygen delivery segment is anticipated to grow at the fastest CAGR (8.21%) during the forecast period. 
• Sizes: The 18G segment dominated the market in 2025, with a revenue share of 30.12%.
• Material: The plastic segment dominated the market in 2025, with a revenue share of 59.26%. 
• End-User: The hospitals and clinics segment dominated the market in 2025 with a market share of 55%, fuelled by the high volume of patient care services and the increasing number of surgical procedures in hospitals and clinics.
• Regional Insights: North America dominated the market in 2025, with a revenue share of 41.02% owing to widespread adoption of safety cannulas driven by strict regulatory frameworks. 

Competitive Players

1. Medtronic
2. BD
3. Edwards Lifesciences Corporation
4. LivaNova PLC
5. United Medical Supply
6. Boston Scientific Corporation
7. ICU Medical, Inc
8. B. Braun
9. Deltamed
10. Medikit Europe GmbH
11. Terumo Cardiovascular Systems Corporation
12. NIPRO
13. Vitality Medical, Inc
14. Cardinal Health
15. ANGIPLAST PRIVATE LIMITED
16. AdvaCare Pharma
17. Narang Medical Limited
18. Romsons
19. CONMED Corporation
20. Fisher & Paykel Healthcare Limited
21. Others

Recent Developments

Segmentation

1. By Product (2026-2034)
   1. Intravenous cannula
      1. Peripheral cannula
      2. Central line cannula
      3. Draining cannula
   2. Nasal cannula
   3. Others
2. By Application (2026-2034)
   1. Oxygen delivery
   2. Anaesthesia and surgery
   3. Blood sampling
   4. Administration of medicine
3. By Sizes (2026-2034)
   1. 14G
   2. 18G
   3. 20G
   4. 22G
   5. Others
4. By Material (2026-2034)
   1. Plastic
   2. Stainless steel
   3. Silicon
5. By End user (2026-2034)
   1. Hospitals and clinics
   2. Ambulatory surgical centres
   3. Others